BR112019004936A2 - extrato de pó vegetal, e purificador de água - Google Patents

extrato de pó vegetal, e purificador de água

Info

Publication number
BR112019004936A2
BR112019004936A2 BR112019004936A BR112019004936A BR112019004936A2 BR 112019004936 A2 BR112019004936 A2 BR 112019004936A2 BR 112019004936 A BR112019004936 A BR 112019004936A BR 112019004936 A BR112019004936 A BR 112019004936A BR 112019004936 A2 BR112019004936 A2 BR 112019004936A2
Authority
BR
Brazil
Prior art keywords
component
exhibits
measurement
fractional
extract
Prior art date
Application number
BR112019004936A
Other languages
English (en)
Inventor
Ito Masahiko
Hasegawa Masato
Shimada Ryu
Fujita Takanori
Original Assignee
Dexerials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexerials Corp filed Critical Dexerials Corp
Priority claimed from PCT/JP2017/032941 external-priority patent/WO2018051992A1/ja
Publication of BR112019004936A2 publication Critical patent/BR112019004936A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C02F1/56—Macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D21/00—Separation of suspended solid particles from liquids by sedimentation
    • B01D21/01—Separation of suspended solid particles from liquids by sedimentation using flocculating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/28—Treatment of water, waste water, or sewage by sorption
    • C02F1/286—Treatment of water, waste water, or sewage by sorption using natural organic sorbents or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/5263—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using natural chemical compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/5272—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using specific organic precipitants
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/58—Treatment of water, waste water, or sewage by removing specified dissolved compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A61K47/6939—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being a polysaccharide, e.g. starch, chitosan, chitin, cellulose or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/5236—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/103—Arsenic compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/12—Halogens or halogen-containing compounds
    • C02F2101/14—Fluorine or fluorine-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds
    • C02F2101/203—Iron or iron compound
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds
    • C02F2101/22—Chromium or chromium compounds, e.g. chromates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Removal Of Specific Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Water Treatment By Sorption (AREA)

Abstract

a presente invenção fornece um extrato, que é um componente fracionado 1 de um extrato aquoso de um pó vegetal, em que o componente fracionado 1 é um componente fracionado com um peso molecular de fracionamento igual ou superior a 12.000, em que um componente não dissolvido em etanol do componente fracionado 1 exibe um pico atribuído ao ácido carboxílico em uma medição de espectroscopia de infravermelho por transformada de fourier (ft-ir) e exibe um pico atribuído à celulose em uma medição de cromatografia gasosa acoplada ao espectro de massas (gc-ms), e em que um componente dissolvido em etanol do componente fracionado 1 exibe um pico atribuído ao ácido carboxílico na medição de ft-ir e exibe um pico atribuído a uma proteína vegetal na medição de gc-ms, e um agente purificador de água contendo o extrato.
BR112019004936A 2016-09-16 2017-09-12 extrato de pó vegetal, e purificador de água BR112019004936A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016181619 2016-09-16
JP2017174021A JP7131894B2 (ja) 2016-09-16 2017-09-11 抽出物の製造方法、抽出物、水浄化剤、及び排水処理方法
PCT/JP2017/032941 WO2018051992A1 (ja) 2016-09-16 2017-09-12 植物粉末の抽出物、及び水浄化剤

Publications (1)

Publication Number Publication Date
BR112019004936A2 true BR112019004936A2 (pt) 2019-06-18

Family

ID=61765750

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019004936A BR112019004936A2 (pt) 2016-09-16 2017-09-12 extrato de pó vegetal, e purificador de água

Country Status (7)

Country Link
US (2) US20190256387A1 (pt)
EP (1) EP3513857B1 (pt)
JP (1) JP7131894B2 (pt)
KR (1) KR102438091B1 (pt)
BR (1) BR112019004936A2 (pt)
RU (1) RU2019110785A (pt)
TW (1) TWI734834B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY192617A (en) 2016-09-16 2022-08-29 Dexerials Corp Extract of plant powder, and water purifier
JP6722807B1 (ja) * 2019-05-31 2020-07-15 デクセリアルズ株式会社 水処理剤及びその製造方法、並びに水処理方法
CN116249675A (zh) * 2020-10-01 2023-06-09 迪睿合株式会社 有机凝结剂及其制造方法、以及水净化剂及其制造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0341014A (ja) * 1989-07-07 1991-02-21 Ichimaru Pharcos Co Ltd モロヘイヤ抽出物含有化粧料
JPH0769910A (ja) * 1993-09-01 1995-03-14 Otsuka Pharmaceut Co Ltd 脂質代謝改善及び血糖上昇抑制組成物
JPH0770208A (ja) * 1993-09-07 1995-03-14 Kyodo Nyugyo Kk モロヘイヤ粘性多糖体の製造法
EP0872490B1 (en) * 1997-04-16 2006-05-17 Sony Corporation High-molecular flocculant, method for producing the flocculant and water-treatment method employing the flocculant
JP3049279B2 (ja) 1997-08-19 2000-06-05 工業技術院長 キトサン及びその製造方法と、高分子凝集剤
JP3876497B2 (ja) * 1997-10-09 2007-01-31 ソニー株式会社 凝集剤及びこれを用いた凝集方法
JP2000140509A (ja) 1998-11-16 2000-05-23 Kansai Kako Kk 新規な凝集剤とそれを用いる汚泥処理方法
WO2005005485A1 (ja) 2003-05-07 2005-01-20 Research Institute For Production Development キチンオリゴマー組成物及び／又はキトサンオリゴリマー組成物、並びにその製造方法
JPWO2004100969A1 (ja) 2003-05-19 2006-07-13 タカラバイオ株式会社 治療剤
JP2008126168A (ja) 2006-11-22 2008-06-05 Fuji Eng Kk 廃水の凝集沈殿処理方法
JP5640419B2 (ja) 2010-03-24 2014-12-17 ソニー株式会社 排水中の重金属イオンの除去方法
JP2011194385A (ja) * 2010-03-24 2011-10-06 Sony Corp 陽イオン交換体、及び排水中の重金属イオンの除去方法
CN102583681B (zh) * 2011-01-14 2014-07-02 索尼公司 植物来源的凝聚剂、凝聚剂混合物、凝聚方法以及制备植物来源的凝聚剂的方法
CN102247814A (zh) 2011-05-17 2011-11-23 中国农业科学院麻类研究所 用于重金属废水处理的生物质吸附剂及重金属废水处理方法
GB201116050D0 (en) 2011-09-16 2011-11-02 Ntnu Technology Transfer As Ionic gel
CN102432692A (zh) 2011-12-27 2012-05-02 西华师范大学 华美牛肝菌多糖
JP2014008428A (ja) * 2012-06-28 2014-01-20 Sony Corp 凝集剤混合物及び凝集方法
WO2014193868A1 (en) 2013-05-29 2014-12-04 Aguas De Manizales S.A. E.S.P. Compositions for water treatment and methods of using thereof
CN103641936B (zh) 2013-12-09 2016-03-23 吴彪 一种采用超滤和纳滤制备水溶性壳寡糖的方法
JP6301802B2 (ja) * 2014-10-03 2018-03-28 デクセリアルズ株式会社 水浄化剤、及び水浄化方法
CN104562632B (zh) * 2015-01-12 2016-08-24 哈尔滨工业大学 一种微波快速改性黄麻制备重金属离子交换纤维的方法及应用
JP6695662B2 (ja) * 2015-02-12 2020-05-20 国立大学法人京都大学 多糖類のナノファイバー、分散媒及びモノマーを含む分散体、並びにその分散体から得られる樹脂組成物

Also Published As

Publication number Publication date
US11866354B2 (en) 2024-01-09
EP3513857A4 (en) 2020-06-03
EP3513857A1 (en) 2019-07-24
RU2019110785A (ru) 2020-10-16
JP2018047454A (ja) 2018-03-29
KR102438091B1 (ko) 2022-08-31
KR20190046992A (ko) 2019-05-07
TW201813933A (zh) 2018-04-16
TWI734834B (zh) 2021-08-01
US20210380444A1 (en) 2021-12-09
US20190256387A1 (en) 2019-08-22
JP7131894B2 (ja) 2022-09-06
EP3513857B1 (en) 2021-05-26

Similar Documents

Publication Publication Date Title
BR112018000632A2 (pt) moléculas de anticorpo que ligam a cd79
BR112015001690A2 (pt) mutações associadas com a resistência a inibidores da tirosina quinase de bruton (btk)
BR112016023630A2 (pt) dispersão aquosa e composição de revestimento compreendendo a mesma
CO2017012995A2 (es) Derivados análogos de heteroarilos/arilo actvos como reguladores nrf2 y composiciones farmacéuticas de los mismos
BR112019004936A2 (pt) extrato de pó vegetal, e purificador de água
BR112018016307A2 (pt) usos de composição e de produto, método de combate a maus odores e composição
BR112012023283A2 (pt) cosmético de cabelo
BR112016010422A8 (pt) suplemento dietético, e uso de uma composição
BR112016012968A2 (pt) Métodos e composições para o tratamento de condições associadas com o envelhecimento
BR112018010271A2 (pt) material cristalino sintético emm-28, sua preparação e uso
BR112017011387A2 (pt) uso de compostos, e, composição cosmética.
WO2015177175A3 (en) Novel specific-binding polypeptides and uses thereof
BRPI0916069C1 (pt) composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição
BR112013016590A2 (pt) uso de estabilizantes de glutamina
BR112018007809A2 (pt) composição de agente de resistência a seco, método para melhorar a força a seco de papel, e, uso de uma composição
BR112018006368A2 (pt) composição para desempenho melhorado
BR112015017251A2 (pt) composições farmacêuticas compreendendo doadores de nitroxil
BR112018007635A2 (pt) ?composição cosmética?
BR112015023209A8 (pt) novos medicamentos compreendendo uma composição de anticorpo enriquecida com uma carga principal de isoforma
BR112019007744A2 (pt) composição de revestimento aquosa, e, métodos de preparação da composição de revestimento aquosa e de concessão de estabilidade de congelamento e descongelamento a um polímero de emulsão acrílica.
BR112017010453A2 (pt) composição adesiva com mudança de cor
BR112018068684A2 (pt) uso de resinas modificadas com ácidos graxos para conferir propriedade antidedadas a uma folha de vidro
BR112019020414A2 (pt) composições e métodos para detectar e tratar câncer de próstata usando moléculas de ligação à progastrina
BR112018014540A2 (pt) formulações/composições compreendendo inibidor de btk
BR112019002199A2 (pt) composto, composição de aquecimento, composição aromatizante ou de fragrância, composição tópica, produto de consumo e método para melhorar, aperfeiçoar ou modificar as propriedades de sabor ou de odor de uma composição aromatizante ou de fragrância

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2595 DE 29-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]